We are your Partner for Strategic Pharma Projects

We provide single cell CRO services globally and support every step of your drug discovery

Single Cell Analysis Services for Biopharma

We take pride in accelerating drug development with cutting-edge single cell solutions. Singleron maximizes the value of your samples through high-quality data generation, rigorous quality control, and advanced bioinformatics interpretation. Trusted globally by leading pharmaceutical companies, our single cell analysis service fuels comprehensive discovery and accelerates the development pipeline

Early stage R&D

Target discovery

High throughput screening

Mechanistic analysis

Clinical trial support and patient stratification

Data integration and advanced bioinformatics

Proven Data Quality

With extensive experience collaborating with leading pharmaceutical companies worldwide on R&D and clinical projects, we ensure the highest data quality that meets your expectations. Our team is trained to meet stringent requirements for sample handling, data quality, confidentiality, and advanced bioinformatics analysis.

5 out of 10

leading global pharma companies collaborated with Singleron

>900

collaborative partners

220+

Copyrights, Patents and Trademarks

>200

customer publications

600+ million

single cells sequenced

Indications

We have built partnerships and collaborated on projects across various fields.

Multiple Myeloma

We are passionate about breakthrough research in Multiple Myeloma, a type of cancer that forms in plasma cells, characterized by the overproduction of abnormal plasma cells in the bone marrow.

Endometriosis

We want to make a change for patients suffering from endometriosis, a medical condition in which tissue similar to the lining of the uterus grows outside the uterus, causing pain and potential fertility issues.

Alzheimer's Disease

We help deciphering Alzheimer's Disease, a progressive neurodegenerative disorder that primarily affects memory, cognitive function, and behavior, leading to a decline in overall mental abilities.

Acute Myeloid Leukemia

Studying AML is essential for advancing medical knowledge, improving patient outcomes, and developing more effective strategies for diagnosis, treatment, and prevention.

Inflammatory Bowel Disease

Unravel the complex etiology of inflammatory bowel disease, understanding the factors influencing disease progression, and develop targeted therapies to improve patient outcomes and quality of life.

Collaborative Highlights

AAIC Poster:
“Increased monocyte activity identified in Alzheimer’s disease by in-depth single-cell genomic and proteomic analysis.”

Stacy Xu, Michael Schulz, PhD2, Ronny Schmidt, PhD3, Mario Richter, PhD2, Marco Klein3, Katrin Hufnagel3, Christoph Schroeder, PhD3 and Jonathan Scolnick, PhD1

1 Singleron Biotechnologies Pte Ltd, Singapore
2 AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany
3 Sciomics GmbH, Heidelberg, Germany

CERTAINTY: Cellular Immunotherapy Virtual Twin for Personalised Cancer Treatment. CERTAINTY provides a ground breaking ecosystem of computational models on multiple biological scales to support cancer patients and their doctors with a personalised treatment strategy with CAR T cells. This pioneering work will transfer the virtual twin concept to patients that are eligible to receive adoptive cellular immunotherapy to
enhance patient individual strategies right from the start.

Let's Discuss Collaborating

Let's Discuss Collaborating

Start your single cell journey with us today!
Contact us to discuss how we can best support your project!